Justice Awaiting: Two Scandals, Two Price Tags – And One Nation Paying

Sri Lanka today finds itself confronting two defining scandals that, while very different in nature, expose the same underlying weakness in governance: the failure to ensure accountability when power is exercised. One unfolded in hospital wards, where consequences are immediate and human. The other emerged within the complex structure of financial markets, where the damage is less visible but far more far-reaching. Together, they tell a deeper story about how institutions fail and who ultimately pays the price.

The case involving Keheliya Rambukwella represents a crisis that is both direct and deeply personal. The procurement of substandard immunoglobulin was not simply an administrative error; it was a breakdown in safeguards within a system meant to protect the most vulnerable. The estimated financial loss of around Rs. 130 million is significant, but it is not the most troubling aspect. The real concern lies in the allegation that patients in state hospitals may have received medicines with no therapeutic value.

In any functioning system, such a failure would trigger not only legal consequences but a thorough institutional review. In this case, the legal machinery moved with unusual speed. Rambukwella was arrested, remanded, and formally charged. The Supreme Court went further, imposing personal liability an extraordinary step that signaled a willingness to hold individuals directly accountable for public harm.

Yet even here, the deeper question lingers: how did procurement safeguards, regulatory oversight, and ministerial responsibility all fail at once? The scandal is not just about wrongdoing, but about the absence of early detection within the system itself.

In contrast, the Central Bank bond scandal linked to Arjuna Mahendran is defined not by immediacy, but by scale and complexity. The 2015 bond auction conducted under the Central Bank of Sri Lanka fundamentally altered the country’s financial landscape. Investigations have identified direct losses exceeding Rs. 11 billion, with broader economic consequences that extend far beyond those initial figures.

The true cost lies in the distortion of financial markets. Elevated bond yields increased the government’s borrowing costs, weakened investor confidence, and contributed to long-term fiscal strain. Unlike the health scandal, where harm is immediate and visible, the financial impact here is gradual, diffused across the entire population.

But it is in the realm of accountability that the contrast becomes most striking and most troubling.

Rambukwella has been arrested, charged, and subjected to judicial scrutiny within Sri Lanka. The legal process, while ongoing, is visibly in motion.

Mahendran, by contrast, remains outside the country, evading arrest despite being a central figure in one of the largest financial scandals in Sri Lanka’s history. Efforts to bring him before Sri Lankan courts have been slow and complex, entangled in legal and international barriers.

The irony is difficult to ignore.

In one case, a scandal involving tens of millions of rupees has led to swift arrests and personal liability. In the other, a controversy involving losses exceeding Rs. 11 billion and potentially far more in long-term economic impact—has yet to result in the physical presence of the მთავარი accused before a Sri Lankan court.

This disparity raises uncomfortable questions about the consistency of justice. Is accountability determined by the scale of harm or by the complexity of the system and the reach of the individual involved?

The health scandal produces immediate victims and moral clarity. The bond scandal disperses its impact across millions, making it less visible but ultimately more consequential. Yet the pace and visibility of justice appear inverted. The more direct the harm, the faster the response. The more systemic the damage, the slower the pursuit.

Both scandals, however, converge in their erosion of public trust. Confidence in healthcare is shaken when patients cannot rely on the medicines they receive. Confidence in economic governance is undermined when financial decisions appear compromised and accountability remains incomplete.

Sri Lanka has seen moments like this before periods of outrage followed by institutional fatigue. The risk is not just that justice is delayed, but that it becomes selective.

The phrase “justice awaiting” now carries a deeper meaning. It is not only about whether courts will deliver verdicts, but whether the system itself can apply the law evenly, regardless of position, complexity, or geography.

The numbers are stark Rs. 130 million in one case, over Rs. 11 billion in another. But the greater issue is not the difference in scale. It is the difference in consequence.

Until that gap is closed, the real cost to Sri Lanka will not just be financial or institutional it will be the continued erosion of belief that justice, when it comes, comes equally for all.

Leave a Reply

Your email address will not be published. Required fields are marked *